Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 798389
Main Authors Ameratunga, Rohan, Woon, See-Tarn, Steele, Richard, Lehnert, Klaus, Leung, Euphemia, Edwards, Emily S J, Brooks, Anna E S
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.01.2022
Subjects
Antibodies, Viral - immunology
antibody deficiency
Common Variable Immunodeficiency - immunology
COVID-19
COVID-19 - immunology
COVID-19 - prevention & control
COVID-19 Vaccines - administration & dosage
COVID-19 Vaccines - immunology
CVID - common variable immunodeficiency disorders
Humans
Immunocompromised Host
Immunology
SARS-CoV-2
SARS-CoV-2 - immunology
T-Lymphocytes - immunology
vaccine responses
COVID-19
vaccine responses
antibody deficiency
SARS-CoV-2
CVID - common variable immunodeficiency disorders
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Mahesh Mohan, Texas Biomedical Research Institute, United States; Filomeen Haerynck, Ghent University, Belgium; Vassilios Lougaris, University of Brescia, Brescia, Italy
This article was submitted to Primary Immunodeficiencies, a section of the journal Frontiers in Immunology
Edited by: Antonio Condino-Neto, University of São Paulo, Brazil
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.798389